Clinical trial
Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia
NCT00169871 · CHU de Quebec-Universite Laval, Other · Completed
Key facts
| NCT number | NCT00169871 |
|---|---|
| Title | Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia |
| Official title | Hs-CRP as Clinical Marker of Inflammatory Atherogenic Dyslipidemia |
| Lead sponsor | CHU de Quebec-Universite Laval, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Dyslipidemia |
| Enrollment | 1,000 |
| Start date | Mar 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 23, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: